TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15087 · Aug 23

#shell#cassowary#docker#freerdp#gnome#hacktoberfest#integration#kde#libvirt#linux#linux_app#nautilus#nix_flake#podman#qemu#qemu_kvm#seamless#winapps#windows#wine#xfce You can run Windows applications like Microsoft Office and Adobe Creative Cloud directly on your Linux desktop (KDE, GNOME, or XFCE) as if they were native apps using WinApps. It works by running Windows inside a virtual machine (using Docker, Podman, or libvirt) and then showing Windows apps seamlessly on Linux with FreeRDP. Your Linux home folder is accessible in Windows, and you can right-click files in Linux to open them with Windows apps. This lets you use all Windows programs without leaving Linux, improving productivity and convenience without needing dual boot or separate hardware. https://github.com/winapps-org/winapps

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment